Chronic lymphocytic leukemia cells diversify and differentiate in vivo via a nonclassical Th1-dependent, Bcl-6–deficient process-Reference-Cited by-同舟云学术

Chronic lymphocytic leukemia cells diversify and differentiate in vivo via a nonclassical Th1-dependent, Bcl-6–deficient process

Published:2016-04-07 Issue:4 Volume:1 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Patten Piers E.M.,Ferrer Gerardo,Chen Shih-Shih,Simone Rita,Marsilio Sonia,Yan Xiao-Jie,Gitto Zachary,Yuan Chaohui,Kolitz Jonathan E.,Barrientos Jacqueline,Allen Steven L.,Rai Kanti R.,MacCarthy Thomas,Chu Charles C.,Chiorazzi Nicholas

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference84 articles.

1. Chronic Lymphocytic Leukemia

2. Gene Expression Profiling of B Cell Chronic Lymphocytic Leukemia Reveals a Homogeneous Phenotype Related to Memory B Cells✪

3. Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia

4. B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes

5. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tuning the B-CLL microenvironment: evidence for BAG3 protein- mediated regulation of stromal fibroblasts activity;Cell Death Discovery;2024-08-28

2. Mouse models of chronic lymphocytic leukemia and Richter transformation: what we have learnt and what we are missing;Frontiers in Immunology;2024-06-06

3. Mouse models of CLL: In vivo modeling of disease initiation, progression, and transformation;Seminars in Hematology;2024-06

4. BCL2 Protein Progressively Declines during Robust CLL Clonal Expansion: Potential Impact on Venetoclax Clinical Efficacy and Insights on Mechanism;Lymphatics;2024-03-28

5. NRX-0492 degrades wild-type and C481 mutant BTK and demonstrates in vivo activity in CLL patient-derived xenografts;Blood;2023-03-30